NanoString Technologies, Inc. (NASDAQ:NSTG) Receives Consensus Rating of “Hold” from Brokerages

Shares of NanoString Technologies, Inc. (NASDAQ:NSTG) have received an average recommendation of “Hold” from the six analysts that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $7.63.

Separately, StockNews.com started coverage on NanoString Technologies in a research report on Wednesday. They issued a “sell” rating on the stock.

NanoString Technologies Price Performance

The business has a 50-day moving average price of $0.36 and a 200 day moving average price of $1.11. NanoString Technologies has a 52 week low of $0.05 and a 52 week high of $11.78. The stock has a market cap of $5.07 million, a PE ratio of -0.03 and a beta of 1.24.

Institutional Trading of NanoString Technologies

Several institutional investors and hedge funds have recently made changes to their positions in NSTG. Guggenheim Capital LLC grew its position in NanoString Technologies by 3.5% in the first quarter. Guggenheim Capital LLC now owns 19,410 shares of the biotechnology company’s stock worth $675,000 after acquiring an additional 659 shares in the last quarter. LPL Financial LLC boosted its holdings in shares of NanoString Technologies by 3.9% in the 2nd quarter. LPL Financial LLC now owns 20,563 shares of the biotechnology company’s stock worth $261,000 after purchasing an additional 779 shares in the last quarter. Advisor Group Holdings Inc. increased its position in shares of NanoString Technologies by 21.1% during the 1st quarter. Advisor Group Holdings Inc. now owns 4,595 shares of the biotechnology company’s stock valued at $162,000 after purchasing an additional 800 shares during the last quarter. First Republic Investment Management Inc. raised its holdings in shares of NanoString Technologies by 4.4% during the 2nd quarter. First Republic Investment Management Inc. now owns 22,393 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 953 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its position in NanoString Technologies by 0.5% in the 1st quarter. Clearbridge Investments LLC now owns 227,288 shares of the biotechnology company’s stock worth $7,898,000 after buying an additional 1,033 shares during the last quarter.

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.